FELBAMATE
Generic: FELBAMATE
ANI PharmaceuticalsManufacturer
ORALRoute
FELBAMATEActive Substance
2015-11-04Original Approval
FELBAMATE is FDA application ANDA202284, sponsored by ANI PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
SEIZURE
225 reports
2
DRUG INEFFECTIVE
183 reports
3
OFF LABEL USE
109 reports
4
SOMNOLENCE
81 reports
5
TOXICITY TO VARIOUS AGENTS
70 reports
6
CONDITION AGGRAVATED
64 reports
7
DRUG INTERACTION
58 reports
8
CONVULSION
53 reports
9
FATIGUE
47 reports
10
GENERALISED TONIC-CLONIC SEIZURE
46 reports